In addition, inhibition of CXCR2 reduces tumorigenesis and angiogenesis in the lung, oesophageal and ovarian cancer (Keane et al., 2004; Wang et al., 2006; Yung et al., 2018). Here, CXCR2 is linked to ovarian cancer.